Anlotinib suppresses proliferation, migration, and immune escape of gastric cancer cells by activating the cGAS-STING/IFN-β pathway

Added 59 days ago (27.04.2022)
Authors: Min Yuan; Xian-Ling Guo; Jian-Hua Chen; Yang He; Zhu-Qing Liu; He-Ping Zhang; Jie Ren; Qing Xu
Journal: Neoplasma
Read article